Genotype comparison | OR [95% CI] | Z (P value) | Heterogeneity of study design | Model | |
---|---|---|---|---|---|
χ2 | I2 | ||||
Overall analysis (5,321 cases, 6,465 controls) | |||||
A allele vs T allele | 1.14 [1.02, 1.26] | 2.33 (0.02) | 59.55 | 71% | Random |
Asian | 1.20 [1.06, 1.36] | 2.87 (<0.01) | 29.42 | 66% | Random |
Caucasian | 0.95 [0.85, 1.07] | 0.87 (0.38) | 7.38 | 32% | Random |
AA vs AT + TT (dominant model) | 1.17 [0.98, 1.38] | 1.78 (0.07) | 40.15 | 58% | Random |
Asian | 1.28 [1.02, 1.61] | 2.11 (0.04) | 24.53 | 59% | Random |
Caucasian | 0.92 [0.79, 1.08] | 1.02 (0.31) | 6.42 | 22% | Fixed |
AA + AT vs TT (recessive model) | 1.18 [1.02, 1.36] | 2.21 (0.03) | 50.59 | 66% | Random |
Asian | 1.26 [1.08, 1.47] | 2.86 (<0.01) | 23.13 | 57% | Random |
Caucasian | 0.90 [0.78, 1.03] | 1.53 (0.13) | 5.29 | 70% | Random |
AA vs TT (homozygous comparison) | 1.26 [1.02, 1.57] | 2.10 (0.04) | 52.95 | 6% | Fixed |
Asian | 1.40 [1.08, 1.83] | 2.50 (0.01) | 27.43 | 64% | Random |
Caucasian | 0.87 [0.73, 1.05] | 1.48 (0.14) | 7.62 | 34% | Fixed |
AT vs TT (heterozygous comparison) | 1.14 [1.00, 1.31] | 1.97 (0.05) | 39.34 | 57% | Random |
Asian | 1.21 [1.09, 1.35] | 3.55 (<0.01) | 18.92 | 47% | Random |
Caucasian | 0.91 [0.78, 1.05] | 1.29 (0.20) | 3.64 | 0% | Fixed |
Gastric cancer analysis (4,513 cases, 6,465 controls) | |||||
A allele vs T allele | 1.15 [1.03, 1.29] | 2.43 (0.02) | 63.29 | 73% | Random |
Asian | 1.23 [1.07, 1.40] | 2.94 (<0.01) | 32.40 | 69% | Random |
Caucasian | 0.95 [0.84, 1.07] | 0.85 (0.40) | 7.46 | 33% | Random |
AA vs AT + TT (dominant model) | 1.17 [0.98, 1.39] | 1.75 (0.08) | 40.38 | 58% | Random |
Asian | 1.28 [1.01, 1.63] | 2.02 (0.04) | 25.37 | 61% | Random |
Caucasian | 0.92 [0.79, 1.09] | 0.95 (0.34) | 6.31 | 21% | Fixed |
AA + AT vs TT (recessive model) | 1.21 [1.03, 1.43] | 2.36 (0.02) | 58.32 | 71% | Random |
Asian | 1.32 [1.09, 1.59] | 2.88 (<0.01) | 29.51 | 66% | Random |
Caucasian | 0.90 [0.78, 1.03] | 1.55 (0.12) | 5.40 | 7% | Fixed |
AA vs TT (homozygous comparison) | 1.29 [1.02, 1.62] | 2.17 (0.03) | 56.20 | 70% | Random |
Asian | 1.46 [1.09, 1.95] | 2.52 (0.01) | 30.52 | 67 | Random |
Caucasian | 0.87 [0.72, 1.05] | 1.44 (0.15) | 7.65 | 35 % | Fixed |
AT vs TT (heterozygous comparison) | 1.18 [1.01, 1.38] | 2.14 (0.03) | 47.23 | 64% | Random |
Asian | 1.27 [1.06, 1.52] | 2.57 (0.01) | 25.47 | 61% | Random |
Caucasian | 0.90 [0.78, 1.05] | 1.33 (0.18) | 3.68 | 0% | Fixed |
Precancerous lesions analysis (808 cases, 1,288 controls) | |||||
A allele vs T allele | 1.09 [0.99, 1.20] | 1.66 (0.08) | 2.98 | 0% | Fixed |
AA vs AT + TT (dominant model) | 1.15 [0.85, 1.56] | 0.90 (0.37) | 1.92 | 0% | Fixed |
AA + AT vs TT (recessive model) | 1.21 [0.99, 1.49] | 1.84 (0.07) | 1.42 | 0% | Fixed |
AA vs TT (homozygous comparison) | 1.27 [0.91, 1.76] | 1.42 (0.16) | 2.37 | 0% | Fixed |
AT vs TT (heterozygous comparison) | 1.19 [0.96, 1.48] | 1.59 (0.11) | 0.69 | 0% | Fixed |